Odeon Capital Taps Veteran Banker for Big Healthcare & Tech M&A Push

NEW YORK, NY – March 02, 2026 – Odeon Capital Group, a New York-based independent broker-dealer, has appointed veteran banker Daniel D’Agostino Jr. as its new Head of Investment Banking, a strategic move signaling an aggressive push into the high-growth healthcare and technology sectors.

D’Agostino, who brings over two decades of experience from firms including RW Pressprich & Co., Deutsche Bank, and BMO, will be tasked with expanding Odeon’s advisory and capital markets platform. The hire is seen by industry observers as a clear declaration of intent by the boutique firm to carve out a larger niche in two of the most active M&A markets.

“Dan’s extensive experience across healthcare and technology makes him uniquely qualified to lead and expand our investment banking platform,” said Evan Schwartzberg, CEO and Co-Founder of Odeon, in a statement. “His strategic insight and deep sector relationships will be instrumental as we continue to grow our advisory and capital markets capabilities.”

D’Agostino expressed his enthusiasm for the new role, stating, “I'm excited to join Odeon Capital. The firm has built a platform that is well positioned for growth, and I look forward to working with Evan and the team to support M&A clients and issuers with thoughtful financing strategies.”

A Strategic Pivot to High-Growth Sectors

The appointment marks a significant strategic inflection point for Odeon Capital’s investment banking division. While the firm has historically provided advisory services across a range of industries, its recent public deal activity has been concentrated in sectors like mining, specialty finance, and metals, with roles as a placement agent for firms like Critical Metals and Defense Metals Corporation. It also served as a co-manager on a SPAC IPO for Titan Acquisition Corp. in the fintech space.

D'Agostino's deep specialization in healthcare and MedTech represents a deliberate pivot toward more targeted, high-value verticals. The move allows Odeon to tap into powerful secular trends driving M&A activity. The healthcare sector continues to see a flurry of deals fueled by innovation in biotechnology, the rapid adoption of digital health and telehealth services, and significant interest from private equity. Likewise, the technology sector remains a hotbed of activity, with M&A driven by the proliferation of artificial intelligence, the necessity of cybersecurity, and the continued dominance of software-as-a-service (SaaS) business models.

By bringing in a leader with a specific mandate for these areas, Odeon is positioning itself to offer the specialized, senior-level advice that corporate clients and financial sponsors demand when navigating complex transactions in these dynamic fields. The strategy is to move beyond generalist advisory and compete directly in arenas where deep domain expertise is a key differentiator.

The 'Rainmaker' Joins the Boutique

D’Agostino fits the classic profile of a “rainmaker”—a senior banker with a proven track record and a portable book of business and relationships. His career trajectory includes senior investment banking roles at major institutions like Deutsche Bank, BMO, and Dillon Read, as well as leadership positions at boutiques like ThinkEquity Partners and AmeriTech Advisors. He also brings direct operational experience, having served as Acting Chief Business Officer and CFO of Synergy Pharmaceuticals.

His move to Odeon reflects a broader industry trend where highly experienced talent migrates from bulge-bracket banks to more nimble, entrepreneurial boutique firms. At a smaller platform, senior bankers can often exercise greater autonomy, have a more direct impact on firm strategy, and offer clients more focused, conflict-free advice. For a firm like Odeon, a hire of D'Agostino's caliber can be transformative, instantly elevating its credibility, expanding its network, and opening doors to new deal flow that might have previously been out of reach.

His extensive background, which includes an MBA from Columbia University and a certificate in biotechnology from the University of Pennsylvania, provides the blend of financial acumen and scientific understanding necessary to lead transactions in the complex life sciences and MedTech industries. His current role on the Board of Directors of ViewMind Inc. further cements his active involvement and expertise within the sector.

Navigating Growth and Competition

Founded in 2008 in the wake of the financial crisis, Odeon Capital has steadily built its business around the motto of providing “bulge bracket expertise and boutique-level service.” The firm has pursued a strategy of targeted growth, methodically strengthening key business lines with experienced leaders. The hiring of D’Agostino follows other strategic appointments in recent years, including new leadership for its credit and U.S. rates desks, indicating a concerted effort to build out a full-service institutional platform.

However, this expansion comes with challenges. The firm is entering a fiercely competitive arena. The healthcare and technology investment banking landscape is crowded with established specialized boutiques like Leerink Partners and MTS Health Partners, as well as the formidable sector teams of middle-market powerhouses like Baird, William Blair, and Raymond James. Success will depend on Odeon's ability to leverage D'Agostino's leadership to not only originate deals but also execute them flawlessly.

This growth push also comes as the firm continues to mature its operational and supervisory functions. In August 2025, Odeon settled with the Financial Industry Regulatory Authority (FINRA), paying a $75,000 fine for supervisory systems that were deemed not reasonably designed to surveil for potentially manipulative trading and for failures in disclosure on certain trade confirmations. Navigating the complexities of a growing business while ensuring robust compliance remains a key task for any expanding financial firm.

With Daniel D’Agostino Jr. at the helm of its investment bank, Odeon Capital is making a calculated bet that his expertise and leadership can accelerate its growth trajectory, enabling the firm to compete and win in some of the most dynamic and rewarding sectors of the M&A market.